1518 - Endoscopic non-contact (side firing) visual laser ablation of the prostate (VLAP) for benign prostatic hyperplasia (BPH)

Page last updated: 05 July 2019

Application Detail



Description of Medical Service

This MSAC application focuses on photoselective vaporisation (PVP) of the prostate using the GreenLight laser system, given it is the VLAP procedure most frequently performed in clinical practice in Australia for BPH.

Description of Medical Condition

BPH is one of the most common diseases of the prostate, characterised by an enlargement of the prostate causing the urethra to narrow and place pressure on the base of the bladder. Narrowing of the urethra can cause problems with the passing of urine in several ways. BPH is often associated with lower urinary tract symptoms (LUTS) which in BPH may be obstructive (includes symptoms such as delay or straining when starting to pass urine, and slow flow of urine) or irritative (includes symptoms such as urgent or frequent urination during the day and night). Furthermore, LUTS associated with BPH are often accompanied by sexual dysfunction, including erectile dysfunction (ED) and ejaculatory problems. While not life-threatening, BPH can be detrimental to a patient’s quality of life. When symptoms of BPH increase in severity, surgical treatment will be considered. Surgical therapy of the prostate is indicated for patients with severe or high impact symptoms.

Reason for Application

Amendment to existing MBS items

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


Consultation Survey


PICO Confirmation


Assessment Report


Public Summary Document

Public Summary Document (PDF 1173 KB)
Public Summary Document (Word 311 KB)

Meetings for this Application


12-13 April 2018


8 February 2019


28-29 March 2019